Novartis Ag (NVS) Total Current Liabilities (2016 - 2025)
Historic Total Current Liabilities for Novartis Ag (NVS) over the last 17 years, with Q4 2025 value amounting to $27.3 billion.
- Novartis Ag's Total Current Liabilities fell 492.82% to $27.3 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $27.3 billion, marking a year-over-year decrease of 492.82%. This contributed to the annual value of $27.3 billion for FY2025, which is 492.82% down from last year.
- Novartis Ag's Total Current Liabilities amounted to $27.3 billion in Q4 2025, which was down 492.82% from $32.0 billion recorded in Q3 2025.
- In the past 5 years, Novartis Ag's Total Current Liabilities ranged from a high of $48.4 billion in Q3 2023 and a low of $26.4 billion during Q4 2023
- Over the past 5 years, Novartis Ag's median Total Current Liabilities value was $29.7 billion (recorded in 2021), while the average stood at $30.4 billion.
- Per our database at Business Quant, Novartis Ag's Total Current Liabilities surged by 7185.01% in 2023 and then plummeted by 4186.76% in 2024.
- Novartis Ag's Total Current Liabilities (Quarter) stood at $30.2 billion in 2021, then dropped by 5.14% to $28.7 billion in 2022, then dropped by 7.91% to $26.4 billion in 2023, then grew by 8.72% to $28.7 billion in 2024, then dropped by 4.93% to $27.3 billion in 2025.
- Its Total Current Liabilities was $27.3 billion in Q4 2025, compared to $32.0 billion in Q3 2025 and $31.7 billion in Q2 2025.